Zobrazeno 1 - 10
of 138
pro vyhledávání: '"Elizabeth B. Humphreys"'
Publikováno v:
Journal of Urology. 199:114-119
We examined the clinical features and outcomes associated with delayed biochemical recurrence after radical prostatectomy, specifically among men with more than 20 years of followup.A total of 16,720 men underwent radical prostatectomy and 2,699 expe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d657b1d989dc3badcde65809a4967102
https://doi.org/10.1016/j.juro.2017.08.041
https://doi.org/10.1016/j.juro.2017.08.041
Autor:
Elizabeth B. Humphreys, Bruce J. Trock, Won Sik Ham, Misop Han, Zhaoyong Feng, Heather J. Chalfin, Alan W. Partin, Carling Cheung, Jonathan I. Epstein
Publikováno v:
European Urology. 71:907-912
Background The newly proposed five-tiered prostate cancer grading system (PCGS) divides Gleason score (GS) 8–10 disease into GS 8 and GS 9–10 on the basis of biochemical recurrence (BCR) following radical prostatectomy (RP) as an outcome. However
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40db1c9269e901e63065a58274f5fd6e
https://doi.org/10.1016/j.eururo.2016.11.006
https://doi.org/10.1016/j.eururo.2016.11.006
Autor:
Angelo M. De Marzo, Misop Han, Elizabeth B. Humphreys, Fawaz Almutairi, Ashley E. Ross, Jessica Hicks, Stephanie Glavaris, Edward M. Schaeffer, Tamara L. Lotan, Debasish Sundi, Carlos L. Morais, Jeffrey J. Tosoian, Bruce J. Trock, Scott A. Tomlins
Publikováno v:
European Urology. 71:697-700
African-American (AA) men have a higher risk of lethal prostate cancer (PCa) compared to European-American (EA) men. However, the molecular basis of this difference, if any, remains unclear. In EA PCa, PTEN loss, but not ERG rearrangement, has been a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb0b0660683171bce7810599fec326db
https://doi.org/10.1016/j.eururo.2016.07.026
https://doi.org/10.1016/j.eururo.2016.07.026
Autor:
Elizabeth B. Humphreys, Misop Han, Jonathan I. Epstein, Carling Cheung, Heather J. Chalfin, Won Sik Ham, Bruce J. Trock, Zhaoyong Feng, Alan W. Partin
Publikováno v:
Journal of Urology. 197:1060-1067
Purpose: Gleason score is one of the most important prognostic indicators for prostate cancer. Downgrading from biopsy Gleason score 7 to radical prostatectomy Gleason score 6 occurs commonly and yet to our knowledge the impact on survival outcomes i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79aba7ee070a956a77f96dffa0b85d2e
https://doi.org/10.1016/j.juro.2016.11.079
https://doi.org/10.1016/j.juro.2016.11.079
Autor:
Neal S. Fedarko, Haikoo Shah, Alka Jain, Alan W. Partin, Elizabeth B. Humphreys, Leslie A. Mangold, Eleanor M. Simonsick, E. Jeffrey Metter
Publikováno v:
Journal of translational autoimmunity
Journal of Translational Autoimmunity, Vol 2, Iss, Pp-(2019)
Journal of Translational Autoimmunity, Vol 2, Iss, Pp-(2019)
Circulating angiotensin type I receptor (AT1R) agonistic autoantibodies (AT1RaAbs) that bind and chronically activate the receptor have been associated with a number of diseases suggesting that while the autoantibodies are not necessarily causative t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45a2fd12afab7a0e226c038677250263
http://europepmc.org/articles/PMC6953913
http://europepmc.org/articles/PMC6953913
Autor:
Evgeny Izumchenko, David Sidransky, Eli Rosenbaum, Elisa Guida, Akira Ooki, Mohammad O. Hoque, Myriam Loyo, Leonel Maldonado, Leslie A. Mangold, Mariana Brait, Mithu Banerjee, Alan W. Partin, Elizabeth B. Humphreys
Publikováno v:
Oncotarget
// Mariana Brait 1, * , Mithu Banerjee 1, * , Leonel Maldonado 1, 4 , Akira Ooki 1 , Myriam Loyo 1 , Elisa Guida 1 , Evgeny Izumchenko 1 , Leslie Mangold 2 , Elizabeth Humphreys 2 , Eli Rosenbaum 5 , Alan Partin 2 , David Sidransky 1, 3 , Mohammad Ob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::933cdf587fea74c908f1e020ff899291
https://doi.org/10.18632/oncotarget.14873
https://doi.org/10.18632/oncotarget.14873
Autor:
Jonathan I. Epstein, Elizabeth B. Humphreys, Bruce J. Trock, Jeffrey J. Tosoian, Zhaoyong Feng, Alan W. Partin, Meera Chappidi, Christian P. Pavlovich, Misop Han
Publikováno v:
BJU International. 119:676-683
Objective To update the Partin Tables for prediction of pathological stage in the contemporary setting and examine trends in patients treated with radical prostatectomy (RP) over the past three decades. Patients and Methods From January 2010 to Octob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d8bf09ccaa85c60f1a83a21a86e6c3f
https://doi.org/10.1111/bju.13573
https://doi.org/10.1111/bju.13573
Autor:
Jeffrey J. Tosoian, Leslie A. Mangold, Edward M. Schaeffer, Elizabeth B. Humphreys, Alan W. Partin, Zeyad Schwen, Ashley E. Ross, Lori J. Sokoll
Publikováno v:
Urology. 90:136-140
Objective To evaluate the association between the Prostate Health Index (PHI) and adverse pathology in a cohort of African American (AA) men undergoing radical prostatectomy. Materials and Methods Eighty AA men with prostate-specific antigen (PSA) of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40beb75c306ae088cc47daa7ca43d779
https://doi.org/10.1016/j.urology.2015.12.004
https://doi.org/10.1016/j.urology.2015.12.004
Autor:
Lucia L. Lam, Stephanie Glavaris, Christine Buerki, Luigi Marchionni, Helen L. Fedor, Michael H. Johnson, Stephania M. Bezerra, Kasra Yousefi, George J. Netto, Voleak Choeurng, Misop Han, Elai Davicioni, Alan W. Partin, Ashley E. Ross, Edward M. Schaeffer, Elizabeth B. Humphreys, Sheila F. Faraj, Nicholas Erho, Bruce J. Trock
Publikováno v:
European Urology. 69:157-165
Radical prostatectomy (RP) is a primary treatment option for men with intermediate- and high-risk prostate cancer. Although many are effectively cured with local therapy alone, these men are by definition at higher risk of adverse pathologic features
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad1d32df17c0581b93590cb1927b9aac
https://doi.org/10.1016/j.eururo.2015.05.042
https://doi.org/10.1016/j.eururo.2015.05.042
Autor:
Leslie A. Mangold, Lynn Sorbara, Paul D. Wagner, Alan W. Partin, Samantha Maragh, Steven P. Lund, Christhunesa S. Christudass, Sudhir Srivastava, Sumit Isharwal, Elizabeth B. Humphreys, Robert W. Veltri
Publikováno v:
Cancer Biomarkers. 15:763-773
Background A 3.4kb deletion (3.4kbΔ ) in mitochondrial DNA (mtDNA) found in histologically normal prostate biopsy specimens has been reported to be a biomarker for the increased probability of prostate cancer. Increased mtDNA copy number is also rep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c99a71c1c10b2d8b0b8a576631b5190
https://doi.org/10.3233/cbm-150518
https://doi.org/10.3233/cbm-150518